Literature DB >> 3028162

Differentiation of sarcoplasmic reticulum during cardiac myogenesis.

W Pegg, M Michalak.   

Abstract

The composition and function of fetal and mature sheep cardiac sarcoplasmic reticulum membranes were investigated. Phospholamban, a major phosphoprotein in the mature sarcoplasmic reticulum membranes, was present in early stages of cardiac myogenesis. This fetal form of phospholamban was phosphorylated by cAMP-dependent protein kinase but not in the presence of Ca2+ and calmodulin. Ca2+ uptake and Ca2+-dependent ATPase activity were low in fetal sarcoplasmic reticulum compared with the adult controls, although the apparent affinities for Ca2+ were similar. Sarcoplasmic reticulum vesicles isolated at all developmental stages had very low levels of plasma membrane (as determined by Na+-K+-ATPase and Na+-Ca2+ exchanger activities) and mitochondrial contamination. Sarcoplasmic reticulum Ca2+ uptake and Ca2+-dependent ATPase activities were not affected by micromolar concentrations of vanadate, and the accumulated Ca2+ could not be released by the addition of NaCl. The amount of both the 110- and 55-kDa protein bands, identified with specific antibodies as Ca2+-ATPase and calsequestrin, respectively, was low in early stages of cardiac myogenesis. Age-related differences in the Ca2+ transport properties of cardiac sarcoplasmic reticulum and in the amount of the Ca2+-ATPase and calsequestrin may explain alterations in the regulation of intracellular Ca2+ concentrations in the fetal heart. This may contribute to the developmental changes in myocardial function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3028162     DOI: 10.1152/ajpheart.1987.252.1.H22

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.

Authors:  Nicole T Feric; Milica Radisic
Journal:  Adv Drug Deliv Rev       Date:  2015-05-05       Impact factor: 15.470

2.  Ontogeny of cytosolic proteins capable of modulating sarcoplasmic reticulum calcium transport in heart muscle.

Authors:  M E Donat; N Su; N Narayanan
Journal:  Mol Cell Biochem       Date:  1991-07-24       Impact factor: 3.396

3.  Relationship between calcium loading and impaired energy metabolism during Na+, K+ pump inhibition and metabolic inhibition in cultured neonatal rat cardiac myocytes.

Authors:  A C Morris; H K Hagler; J T Willerson; L M Buja
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

4.  Subfractionation of cardiac sarcolemma with wheat-germ agglutinin.

Authors:  J H Charuk; S Howlett; M Michalak
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

Review 5.  Development of the myocardial contractile system.

Authors:  T Nakanishi; M Seguchi; A Takao
Journal:  Experientia       Date:  1988-12-01

6.  Identification of the Ca2+-release activity and ryanodine receptor in sarcoplasmic-reticulum membranes during cardiac myogenesis.

Authors:  M Michalak
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

7.  Concurrent Use of Calcium Chloride and Arginine Vasopressin Infusions in Pediatric Patients with Acute Cardiocirculatory Failure.

Authors:  Karan B Karki; Jeffrey A Towbin; Camden Harrell; James Tansey; Joseph Krebs; William Bigelow; Arun Saini; Sachin D Tadphale
Journal:  Pediatr Cardiol       Date:  2019-05-07       Impact factor: 1.655

8.  Free radical-induced protein modification and inhibition of Ca2+-ATPase of cardiac sarcoplasmic reticulum.

Authors:  Peter Kaplan; Eva Babusikova; Jan Lehotsky; Dusan Dobrota
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

9.  Polychlorinated biphenyls reduce the kinematics contractile properties of embryonic stem cells-derived cardiomyocytes by disrupting their intracellular Ca2+ dynamics.

Authors:  Paola Rebuzzini; Estella Zuccolo; Cinzia Civello; Lorenzo Fassina; Juan Arechaga; Amaia Izquierdo; Pawan Faris; Maurizio Zuccotti; Francesco Moccia; Silvia Garagna
Journal:  Sci Rep       Date:  2018-12-17       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.